Hikma Pharmaceuticals (LON:HIK) Stock Price Crosses Above 200 Day Moving Average – Time to Sell?

Hikma Pharmaceuticals PLC (LON:HIK)’s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 2,048.74 ($27.66) and traded as high as GBX 2,144 ($28.95). Hikma Pharmaceuticals shares last traded at GBX 2,096 ($28.30), with a volume of 539,987 shares traded.

Wall Street Analysts Forecast Growth

Several research firms recently commented on HIK. JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Hikma Pharmaceuticals in a research report on Friday, March 7th. Berenberg Bank restated a “buy” rating and issued a GBX 2,560 ($34.56) price target on shares of Hikma Pharmaceuticals in a research report on Monday, March 10th.

Hikma Pharmaceuticals Stock Performance

The company has a debt-to-equity ratio of 55.82, a quick ratio of 1.27 and a current ratio of 1.66. The stock has a market cap of £5.81 billion, a P/E ratio of 20.57, a price-to-earnings-growth ratio of 2.38 and a beta of 0.41. The company’s 50 day moving average price is GBX 1,984.81 and its 200-day moving average price is GBX 2,048.74.

Insider Buying and Selling at Hikma Pharmaceuticals

In other Hikma Pharmaceuticals news, insider Victoria Hull sold 2,777 shares of the stock in a transaction that occurred on Tuesday, April 8th. The shares were sold at an average price of GBX 1,800 ($24.30), for a total transaction of £49,986 ($67,484.81). Also, insider Said Darwazah sold 13,863 shares of the stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of GBX 2,138 ($28.86), for a total transaction of £296,390.94 ($400,149.78). Insiders own 30.54% of the company’s stock.

Hikma Pharmaceuticals Company Profile

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.